2181
DSMM XI study : dose definition for intravenous cyclophosphamide in combination with bortezomib / dexamethasone for remission induction in patients with newly diagnosed myeloma .
 Chemical: cyclophosphamide; Chemical: bortezomib; Chemical: dexamethasone; Disease: myeloma
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: cyclophosphamide; Chemical: bortezomib; Chemical: dexamethasone; Disease: myeloma